PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsKythera Biopharmaceuticals
Kythera Biopharmaceuticals(KYTH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Terfenadine
neoplasm metastasis
,
breast neoplasms
,
triple negative breast neoplasms
,
non-small-cell lung carcinoma
Dexibuprofen
agnosia
,
postoperative pain
,
dental pins
,
toothache
,
osteoarthritis
,
acute pain
Trinessa
healthy volunteers/patients
,
pneumonia
,
community-acquired infections
,
bacterial pneumonia
Fluoroquinolone
infections
,
acquired immunodeficiency syndrome
,
asthma
,
bacterial infections
,
thrombocytopenic purpura idiopathic
,
purpura
,
photosensitivity disorders
,
renal cell carcinoma
,
chronic obstructive pulmonary disease
,
human influenza
,
healthy volunteers/patients
,
anemia
,
respiratory tract infections
,
acute coronary syndrome
,
vivax malaria
,
premature obstetric labor
,
premature birth
,
vomiting
,
nausea
,
type 2 diabetes mellitus
,
alzheimer disease
,
pulmonary tuberculosis
,
tuberculosis
,
neoplasms
,
prostatic hyperplasia
,
prostatitis
,
neutropenia
,
fever
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use